Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM-HF trial.
Zakeri R, Morgan JM, Phillips P, Kitt S, Ng GA, McComb JM, Williams S, Wright DJ, Gill JS, Seed A, Witte KK, Cowie MR; REM-HF Investigators.
Zakeri R, et al.
Eur J Heart Fail. 2020 Mar;22(3):543-553. doi: 10.1002/ejhf.1709. Epub 2020 Jan 7.
Eur J Heart Fail. 2020.
PMID: 31908129
Free article.
Clinical Trial.
Three categories were defined based on total AF duration during the first year of follow-up: (i) no AF (n = 1211, 77.6%), (ii) paroxysmal AF ( 6 min to 7 days; n = 92, 5.9%), and (iii) persistent/permanent AF (>7 days; n = 258, 16.5%). ...
Three categories were defined based on total AF duration during the first year of follow-up: (i) no AF (n = 1211, 77.6%), (ii) paroxysmal AF …